Meridian Venture Partners II GP, L.P., 10% Owner at ANI PHARMACEUTICALS INC (ANIP), sold 15,158 shares at $68.30 ($1.0M) on 2019-08-19, disclosed to the SEC on 2019-08-23.
Scheduled sale ($1.0M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $68.30 | 2,067 | $141K | 13.7% |
| 2 | $68.30 | 2,067 | $141K | 13.7% |
| 3 | $68.18 | 5,512 | $376K | 36.3% |
| 4 | $68.18 | 5,512 | $376K | 36.3% |
| Total | $68.21 avg | 15,158 | $1.0M | 100% |
| Filing → |